Artelo Biosciences (ARTL)
(Delayed Data from NSDQ)
$1.19 USD
-0.01 (-0.62%)
Updated Sep 9, 2024 09:53 AM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
Artelo Biosciences, Inc. (ARTL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$5.00 | $5.00 | $5.00 | 316.67% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Artelo Biosciences, Inc. comes to $5.00. The forecasts range from a low of $5.00 to a high of $5.00. The average price target represents an increase of 316.67% from the last closing price of $1.20.
Analyst Price Targets (2 )
Broker Rating
Artelo Biosciences, Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on three recommendations.
Of the two recommendations deriving the current ABR, two are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/ARTL.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/29/2024 | Maxim Group | Michael Okunewitch | Strong Buy | Strong Buy |
6/5/2024 | H.C. Wainwright & Co. | Vernon Bernardino | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 2 |
Average Target Price | $5.00 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 86 of 253 |
Current Quarter EPS Est: | -0.41 |
ARTL FAQs
Artelo Biosciences, Inc. (ARTL) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 2 brokerage firms.
The average price target for Artelo Biosciences, Inc. (ARTL) is $5.00. The current on short-term price targets is based on 1 reports.
The forecasts for Artelo Biosciences, Inc. (ARTL) range from a low of $5 to a high of $5. The average price target represents a increase of $316.67 from the last closing price of $1.20.
The current UPSIDE for Artelo Biosciences, Inc. (ARTL) is 316.67%
Based on short-term price targets offered by two analysts, the average price target for Artelo Biosciences, Inc. comes to $5.00. The forecasts range from a low of $5.00 to a high of $5.00. The average price target represents an increase of 316.67% from the last closing price of $1.20.